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Abstract
 
The essential upstream steps in granzyme B–mediated apoptosis remain undefined. Herein, we
show that granzyme B triggers the mitochondrial apoptotic pathway through direct cleavage of
Bid; however, cleavage of procaspases was stalled when mitochondrial disruption was blocked
by Bcl-2. The sensitivity of granzyme B–resistant Bcl-2–overexpressing FDC-P1 cells was re-
stored by coexpression of wild-type Bid, or Bid with a mutation of its caspase-8 cleavage site,
and both types of Bid were cleaved. However, Bid with a mutated granzyme B cleavage site
remained intact and did not restore apoptosis. Bid with a mutation preventing its interaction
with Bcl-2 was cleaved but also failed to restore apoptosis. Rapid Bid cleavage by granzyme B
(
 
,
 
2 min) was not delayed by Bcl-2 overexpression. These results clearly placed Bid cleavage
upstream of mitochondrial Bcl-2. In granzyme B–treated Jurkat cells, endogenous Bid cleavage
and loss of mitochondrial membrane depolarization occurred despite caspase inactivation with
z-Val-Ala-Asp-fluoromethylketone
 
 
 
or Asp-Glu-Val-Asp-fluoromethylketone. Initial partial
processing of procaspase-3 and -8 was observed irrespective of Bcl-2 overexpression; however,
later processing was completely abolished by Bcl-2. Overall, our results indicate that mitochon-
drial perturbation by Bid is necessary to achieve a lethal threshold of caspase activity and cell
death due to granzyme B.
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Introduction
 
CTLs and NK cells utilize two mechanisms to kill virus-
 
infected and premalignant cells, both of which require direct
 
effector–target cell contact. In one mechanism, engagement
of cell surface Fas (CD95) molecules by Fas ligand (FasL) on
the effector cell recruits a signaling complex to the inner
leaflet of the target cell membrane, resulting in activation of
procaspase-8 (1). This mechanism mediates lymphoid ho-
meostasis in higher animals (2). The second mechanism uti-
lizes granule-bound toxins, most importantly a membra-
nolytic agent, perforin, and the serine protease, granzyme
B, which are liberated from secretory vesicles in the killer
cell cytoplasm into the target cell (3). This mechanism is es-
sential for host protection against some virus infections and
cellular transformation (4). Studies with gene knockout
mice indicate that perforin is indispensable for eliciting ap-
optosis in concert with granzymes (4). Although perforin
cannot induce apoptotic death per se, it provides access for
proapoptotic granzymes to death substrates in the target
cell, thus initiating the death cascade (5–8). Perforin’s essen-
tial role probably involves disruption of granzyme-contain-
ing target cell endosomes, as its function can be accurately
mimicked by endosomolytic agents such as adenovirus (8),
 
listeriolysin, and pneumococcal pneumolysin (PLO)
 
1
 
 with-
out the requirement for large transmembrane pores (3).
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Abbreviations used in this paper:
 
 Apaf-1, apoptotic protease-activating fac-
tor 1; IAP, inhibitor of apoptosis proteins; PLO, pneumococcal pneumol-
ysin; t, truncated; TUNEL, terminal deoxynucleotidyl transferase–medi-
ated dUTP-biotin nick-end labeling. 
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The granzymes are structurally related, but have diverse
substrate preferences. Through its unique ability to cleave
after aspartate residues, granzyme B can cleave many pro-
caspases in vitro (9–11) and is highly toxic to target cells
(5). Not surprisingly, it has been assumed until now that
granzyme B kills cells by direct caspase activation, supple-
mented under certain circumstances by direct damage to
downstream caspase substrates (12). Having accessed the
cytosol, granzyme B is rapidly translocated to the nucleus
(13) and can cleave poly(ADP-ribose) polymerase and nu-
clear matrix antigen, sometimes using different cleavage
sites than those preferred by caspases (12). Although many
procaspases are efficiently cleaved in vitro, granzyme
B–induced caspase activation occurs in a hierarchical manner
in intact cells, commencing at the level of executioner
caspases such as caspase-3, followed by caspase-7 (14). This
is in contrast to FasL-mediated killing, which relies on a
membrane signal generated through apical caspases such as
caspase-8 (15, 16). Surprisingly, granzyme B can also in-
duce death through a caspase-independent mechanism that
involves direct damage to nonnuclear structures, although
the key substrates in this pathway have yet to be elucidated
(17–20). These additional pathways probably safeguard
against viruses that delay programmed cell death by ex-
pressing serpins such as the efficient caspase-8 inhibitor
crmA elaborated by cowpoxvirus (21) and baculovirus p35,
which inhibits a broader range of caspases (22).
Although several apoptotic pathways have been attrib-
uted to granzyme B, the essential upstream steps that im-
part the death signal have not been defined. It has been
considered a fait accompli by many investigators that this
step simply involves the direct activation of caspases; how-
ever, this proposition has not been rigorously tested, nor is
it consistent with all of the published evidence. For exam-
ple, we (23, 24) and other groups (25) have shown that
Bcl-2 and related inhibitors such as Epstein-Barr virus
BHRF1 (26) can block both the caspase-dependent and
-independent pathways to granzyme B–mediated apoptosis.
Importantly, we confirmed that all granzyme B death path-
ways were blocked in Bcl-2–expressing cells, using long-
term assays of cell growth and clonogenic capacity (24).
We found that Bcl-2 overexpression had no effect on
granzyme B uptake into the cell cytoplasm or sensitivity to
perforin lysis, but its redistribution to the nucleus after per-
forin addition was totally inhibited (27). MacDonald et al.
(28) also recently reported that granzyme B–mediated cell
death was enhanced by the addition of mitochondria to in
vitro apoptotic extracts of cells treated with granzyme B,
and postulated that mitochondrial factors greatly amplify
extramitochondrial caspase activation. The finding that
Bcl-2 could rescue cells from granzyme B–mediated cell
death was unexpected, as Bcl-2 and related molecules are
thought to specifically block only those pathways that op-
erate directly through mitochondrial perturbation, such as
growth factor withdrawal, irradiation, and exposure to cer-
tain toxins. Bcl-2 and BHRF1 suppress the mitochondrial
pathway by preventing loss of mitochondrial membrane
depolarization and inhibiting the release of cytochrome c
 
and apoptosis-inducing factor into the cytosol (29). Collec-
tively, these results strongly suggested that mitochondrial
constituents are essential for granzyme B–mediated apopto-
sis, and that this pathway can be regulated by Bcl-2. How-
ever, it was difficult to reconcile these findings with
granzyme B’s demonstrated ability to directly activate many
caspases in vitro.
Granzyme B’s “preference” for activating the mitochon-
drial pathway raised other important issues. In particular,
how does Bcl-2 overexpression regulate granzyme B when
there is no evidence that the two molecules interact di-
rectly (Sutton, V.R., unpublished data)? Instead, we postu-
lated that the proapoptotic signal from granzyme B is prob-
ably transmitted to mitochondria through an intermediary
molecule. Much recent attention had been focused on the
proapoptotic Bcl-2 family member, Bid, a BH3 domain-
only protein that has been shown to be cleaved in vitro by
both granzyme B and caspases (especially caspase-8) at sep-
arate Asp residues. Recently, Bid cleavage was also shown
to occur in cells treated with granzyme B, but the signifi-
cance of this finding to cell death was not extensively can-
vassed (30). It has also been proposed that recruitment of
the mitochondrial pathway may amplify suboptimal stimu-
lation of the caspase cascade after Fas ligation in some cell
types (31). This pathway involves mitochondrial disruption
after insertion of truncated (t)Bid into the mitochondrial
membrane.
In this study, we examined the possibility that direct Bid
cleavage by granzyme B is necessary to transmit the death
signal through the mitochondrion. Consistent with our
previous data (23, 24), the proapoptotic activity of tBID
can be negatively regulated by Bcl-2 overexpression, indi-
cating that this pathway is indispensable for cell death. In
the presence of normal Bcl-2 levels, tBid-mediated mito-
chondrial disruption would be necessary to achieve a lethal
threshold of caspase activation, leading to caspase-mediated
apoptosis. This mechanism would also account for granzyme
B’s ability to kill cells independently of caspases (through
direct mitochondrial disruption) when caspases are inacti-
vated, for instance by a viral inhibitor.
 
Materials and Methods
 
Cell Culture and Gene Transfection.
 
FDC-P1 IL-3–dependent
mouse myeloid cells were cultured in DMEM supplemented
with 10% FCS and IL-3 in a humidified CO
 
2 
 
incubator. Jurkat
human T leukemia cells were maintained in RPMI supple-
mented with 10% FCS.
Populations of FDC-P1 cells expressing human Bcl-2 cDNA
in the vector pEFpuro, and/or wild-type mouse Bid or one of
three Bid mutants in pEF EE1hygro were generated by gene
transfection, using electroporation of plasmid DNA, as described
(32). One construct encoded Bid cDNA that encoded Glu rather
than Asp at position 59 (D59E); another encoded Glu rather than
Asp at residue 75 (D75E); and a third encoded Ala instead of Leu
at residue 90. Bid molecules were tagged with an “EE” epitope to
permit detection with a specific mouse Ab (BAbCO). Wild-type
FDC-P1 cells or cells transfected only with the vector backbone
expressed low endogenous levels of Bcl-2 (data not shown). The 
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Bcl-2 construct was used to produce Jurkat cell populations ex-
pressing wild-type Bcl-2 in their mitochondria, as described (24).
 
Characterization of FDC-P1 Cells Expressing Bcl-2 and/or Bid.
 
Intracellular staining of transfected cells was performed as de-
scribed (33). Primary Abs were mouse mAbs detecting human
Bcl-2 or the EE epitope on Bid-expressing constructs. Specific
binding of mouse Ig was detected with FITC-conjugated anti–
mouse Ig (Silenus). Stained, fixed cells were analyzed on a cyto-
fluorograph (Becton Dickinson). For Western blotting, lysates of
washed cells (10
 
6
 
) were fractionated on SDS-PAGE with reduc-
ing agent, transferred to nylon, and probed with the above mAbs.
Signals were detected by exposure to x-ray film after chemilumi-
nescent amplification. For growth factor withdrawal assays, cells
in exponential growth were washed four times in PBS, then re-
cultured in their usual medium lacking IL-3. Cells were plated in
24-well tissue culture dishes (2 
 
3
 
 10
 
5
 
 cells/ml) and cell viability
was determined by dye exclusion. Alternatively, cells were cul-
tured in medium containing staurosporine for 24 h and their via-
bility was estimated in the same way.
 
Apoptosis Assays.
 
Terminal deoxynucleotidyl transferase–medi-
ated dUTP-biotin nick-end labeling (TUNEL) assays were per-
formed as described previously (18, 23). Perforin was purified
from rat NK cells as described (23). Recombinant PLO was a gift
of Dr. J. Paton (Children’s and Women’s Hospital, Adelaide,
Australia). A sublytic dose of perforin or PLO was that producing
 
,
 
10% specific release of 
 
51
 
Cr over 4 h. Purification of human
granzyme B from YT cells was as described (34). The granzyme
B was free of granzyme A activity and perforin (7, 34). The pep-
tide inhibitors z-Val-Ala-Asp-fluoromethylketone (z-VAD-fmk),
Asp-Glu-Val-Asp-fluoromethylketone (DEVD-fmk), and Phe-
Ala-fluoromethylketone (z-FA-fmk) were purchased from En-
zyme Systems Products. In some experiments, Jurkat cells were
treated with mouse anti-Fas IgM Ab (250 ng/ml CH11; Upstate
Biotechnology). Changes in mitochondrial membrane potential
were measured by flow cytometry with the mitochondrion-spe-
cific fluorescent dye, rhodamine 123, as described (24).
 
Western Blotting.
 
Protein lysates were transferred from SDS-
PAGE to Immobilon membranes using a semidry transfer cell
(Bio-Rad Laboratories). For assays examining the release of cyto-
chrome c into the cytosol, cells were exposed to granzyme B and
sublytic PLO with or without fmk inhibitors, lysed, and fraction-
ated (35). The membranes were probed with antisera specific for
caspase-3 (Transduction Laboratories), caspase-9 (a gift of Dr. X.
Wang, University of Texas Southwestern Medical Center at Dal-
las, Dallas, TX), caspase-8 (a gift of Dr. H. Walczak, German
Cancer Research Center, Heidelberg, Germany), Bid (a gift of
Dr. X. Wang), or cytochrome c (clone 7H8; BD PharMingen).
Bound Ig was detected with rabbit anti–mouse or swine anti–rab-
bit reagent coupled to horseradish peroxidase after chemilumi-
nescence amplification.
 
Results
 
Bid Is Upstream of Bcl-2 in the Granzyme B Death Pathway.
 
Our previous studies showing that Bcl-2 overexpression
blocks the apoptotic changes induced by granzyme B (23)
and restores clonogenic survival to target cells (24) indi-
cated that Bcl-2 regulates a key upstream event in the
granzyme B death pathway. As there is no evidence that
Bcl-2 can directly inhibit granzyme B, we hypothesized
that Bcl-2 probably acts indirectly on a proapoptotic sub-
strate activated by granzyme B and acting through the mi-
 
tochondrial pathway. Bid is known to be cleaved in vitro
by granzyme B exclusively at the Asp residue at position 75
(D75; and by caspase-8 at an alternative site, D59; refer-
ence 36), and therefore seemed a likely candidate to trans-
mit a granzyme B–initiated death signal to the mitochon-
drion.
We reasoned that if Bid is upstream of Bcl-2 in the
granzyme B apoptotic pathway, cooveexpression of Bid in
cells overproducing Bcl-2 should relieve the block to cell
death. Therefore, we produced uncloned populations of
factor-dependent FDC-P1 cells that expressed mouse Bid
and/or Bcl-2. Intracellular FACS
 
®
 
 staining (Fig. 1) demon-
strated cell populations that expressed high, unimodal levels
of Bcl-2 alone (FD.bcl2), Bid alone (FD.bid), or both mol-
ecules (FD.bcl2/bid). It was demonstrated by immuno-
staining that overexpressed Bcl-2 was localized to the mi-
tochondrial membrane and endoplasmic reticulum (data
not shown). Furthermore, deliberate missorting of the Bcl-2
to the cell membrane abrogated its ability to block
granzyme B–mediated cell death (24). This panel of cell
lines was exposed to granzyme B (60 nM) and/or a sublytic
concentration of perforin. Cells exposed to perforin (Fig. 2)
or granzyme B alone (data not shown) remained viable in-
definitely, and showed no changes of apoptosis in TUNEL
analysis. Consistent with previous findings, FDC-P1 cells
exposed to both perforin and granzyme B for 60 min de-
veloped apoptotic changes, including DNA fragmentation
(TUNEL positive), reduced size (reduced forward scatter),
and increased granularity (increased side scatter). These
changes were abrogated by Bcl-2 overexpression, but were
restored when Bid was cooverexpressed with Bcl-2 or
overexpressed alone. Analogous results were obtained
when PLO was substituted for perforin (data not shown).
These findings clearly indicated that Bid is upstream of Bcl-2
in the granzyme B death pathway.
Figure 1. The expression of Bcl-2
and Bid in FDC-P1 transfectant popula-
tions. Expression of human Bcl-2 (thick
lines) and Bid (thin lines) after gene
transfection. FDC-P1 cells expressing
either Bcl-2 or Bid alone, or both mole-
cules (middle) were permeabilized,
stained, and analyzed by flow cytometry
using mouse mAbs specific for human
Bcl-2 or EE-tagged Bid. Fluorescence
staining in each case is compared with
that with the FITC-conjugated anti–
mouse reagent alone (dotted lines). 
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Bid Does Not Reverse Bcl-2 Inhibition of Apoptosis Due to
Growth Factor Withdrawal or Staurosporine.
 
As expected,
cell death in response to both IL-3 withdrawal (Fig. 3 A)
and staurosporine (Fig. 3 B), stimuli that operate through
the mitochondrial pathway (37), was inhibited by Bcl-2.
However, in contrast to granzyme B, cells remained com-
pletely protected despite overexpression of Bid with Bcl-2
(Fig. 3). Western blots were performed to determine
whether Bid is cleaved in response to granzyme B, factor
withdrawal, or staurosporine (Fig. 4). Exposure of cells
overexpressing only Bid to the combined effects of sublytic
 
perforin and granzyme B resulted in virtually complete loss
of intact (
 
z
 
25 kD) Bid within 30 min, and the appearance
of truncated forms of 
 
z
 
13, 15, and 16 kD (Fig. 4 A).
However, treatment with perforin alone (Fig. 4 A) or
granzyme B alone (data not shown) did not result in Bid
cleavage. Cooverexpression of Bcl-2 did not prevent Bid
cleavage when both granzyme B and perforin were added
to the cells, although the rate of Bid depletion was some-
what slowed (see below). These results contrasted starkly
when cells were deprived of growth factor or exposed to
staurosporine (Fig. 4 B). In cells overexpressing only Bid,
incomplete cleavage of 25-kD Bid was observed, but this
was totally blocked for 
 
.
 
18 h by cooverexpression of Bcl-2.
As has previously been noted for staurosporine treatment
Figure 2. Cooverexpression
of Bid overcomes Bcl-2’s block
of granzyme B–mediated cell
death. Cytofluorographic analy-
sis of cells, showing DNA frag-
mentation (TUNEL assay) and
changes in light scatter parame-
ters (forward vs. side scatter) of
cells treated with sublytic per-
forin (Pfp; top panels) or perforin
in combination with granzyme B
(GrB, 60 nM; bottom panels) for
90 min at 378C. The cells were
wild-type FDC-P1, or FDC-P1
cells stably expressing human
Bcl-2, Bid, or both Bcl-2 and
Bid (see Fig. 1). The numerals in
each panel indicate the percent-
age of TUNEL-positive cells, to
the nearest integer. The experi-
ment shown is representative of
four similar experiments.
Figure 3. Bid expression does not overcome Bcl-2’s block of cell death
due to growth factor withdrawal or staurosporine. (A) Wild-type FDC-
P1 cells, or FDC-P1 cells stably expressing human Bcl-2, Bid, or both
Bcl-2 and Bid (see Fig. 1) were washed extensively and plated in culture
medium lacking IL-3. Cell viability was estimated at the times indicated
by trypan blue exclusion. (B) The same cell populations were plated in
medium containing staurosporine for 18 h, or in normal medium, and
cell viability was estimated by trypan blue exclusion. The experiment
shown is representative of four similar experiments.
Figure 4. Bid cleavage in Bcl-
2–overexpressing FDC-P1 cells
after exposure to granzyme B,
but not after growth factor with-
drawal or exposure to staurospo-
rine (STS). (A) Western blot
analysis of whole cell lysates of
FDC-P1 cells stably expressing
only Bid or both Bid and Bcl-2,
after exposure to sublytic per-
forin alone (Pfp) or a combina-
tion of perforin and granzyme B
(GrB) for 15–60 min. The sig-
nals for uncleaved and tBid are
indicated with arrowheads. (B)
Western blot of whole cell ly-
sates of the same FDC-P1 cell
transfectants as in A after with-
drawal of growth factor or exposure to staurosporine for 18 h. Both blots
were reprobed with an antiserum specific for tubulin (T; 50 kD) to assess
protein loading. The migration of relevant molecular size markers is indi-
cated in kilodaltons at left. 
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(38), it is likely that Bid cleavage in response to IL-3 with-
drawal is also downstream of Bcl-2.
 
The Granzyme B Cleavage Site in Bid (Asp 75) Is Essential
for Reversing Bcl-2’s Block of Cell Death.
 
As independent
Bid cleavage sites have been identified for granzyme B and
caspases, including caspase-8 (36), it was important to iden-
tify which site is necessary for granzyme B–induced cell
death. Therefore, we made a further series of FDC-P1
transfectant cell lines. In one, Bid was overexpressed with
the granzyme B cleavage site abolished by mutation of D75
to Glu (D75E). As a control, a similar mutation was made
in the preferred caspase-8 site (D59E). We compared the
ability of both Bid mutants and wild-type Bid to restore
cell death inhibited by Bcl-2 overexpression (Fig. 5 A).
When the cells were treated with perforin (or PLO) and
granzyme B, mutation of the granzyme B cleavage site
(D75E) abolished the apoptotic phenotype seen with wild-
type Bid. By contrast, loss of the caspase-8 site (D59) did
not prevent Bid from overcoming Bcl-2’s block of cell
death. No Bid cleavage was seen when the granzyme B site
was lost (Fig. 5 B), despite the availability of caspase sites,
including D59. In contrast, the Bid mutant lacking the
caspase-8 site was still cleaved in the typical way. Loss of
Bid cleavage with the D75E mutant, but not by the D59E
mutant, indicated that the cleavage was mediated directly
by granzyme B, and did not result from activation of
caspase-8 by granzyme B (see also below). It has previously
been shown that mutation of the Bid BH3 domain inacti-
vates Bid by preventing its interaction with Bcl-2 (39).
When we coexpressed this mutant (L90A) with Bcl-2, ex-
 
posure to granzyme B resulted in Bid cleavage, as indicated
by loss of the signal for intact Bid (Fig. 5 C). However, this
mutant was completely unable to relieve Bcl-2’s block of
granzyme B, as only background levels of cell death (
 
,
 
5%)
were seen after granzyme B and perforin addition (data not
shown). This indicated that granzyme B–cleaved wild-type
or D59E-mutated Bid overcame the block to cell death by
interaction with Bcl-2 at the mitochondria.
 
Cleavage of Endogenous Bid Is Rapid, Precedes Caspase Acti-
vation, and Is Not Delayed by Overexpression of Bcl-2.
 
All of
the studies described above used FDC-P1 cells expressing
supraphysiological levels of Bid and/or Bcl-2. We next ex-
amined the processing of endogenous Bid in Jurkat cells
exposed to granzyme B. Bid cleavage was once again ob-
served in response to granzyme B (60 nM) delivered by ei-
ther sublytic perforin or PLO (Fig. 6). All of the endoge-
nous Bid was cleaved within 2 h, consistent with the
characteristically rapid activation of apoptosis by granzyme
Figure 5. The granzyme B cleavage site of Bid (D75) is essential to overcome Bcl-2’s block of granzyme B–mediated cell death, but the caspase-8
cleavage site (D59) is not. (A) Cytofluorographic analysis, showing DNA fragmentation (TUNEL assay) and changes in light scatter parameters (forward
vs. side scatter) of cells exposed to sublytic PLO with granzyme B (60 nM) for 60 min at 378C. The cells were Bcl-2–overexpressing FDC-P1 cells also
expressing wild-type Bid or Bid in which the P1 Asp at the granzyme B cleavage site was mutated to Glu (D75E), or in which the P1 Asp at the cas-
pase-8 cleavage site was mutated to Glu (D59E). The numerals in each panel indicate the percentage of TUNEL-positive cells, to the nearest integer. The
experiment shown is representative of three similar experiments performed with either PLO or perforin. No significant apoptosis was detected when the
cells were exposed to either sublytic quantities of perforin/PLO or granzyme B alone (,2%; data not shown). (B) Western blot using anti-EE antiserum
of D59E and D75E cells shown in A. The cells were incubated with sublytic PLO (P) with or without granzyme B (GrB; 30 nM) at 378C for 15–60 min,
as indicated. Tubulin (T) staining has been used to ensure approximately equal protein loading in the samples. (C) Western blot analysis of whole cell
lysates of FDC-P1 cells stably expressing L90A-mutated Bid and Bcl-2, after exposure to sublytic PLO or a combination of PLO and granzyme B for
15–60 min. The signal for uncleaved Bid is indicated. Staining of the same samples with antitubulin (T) was used to normalize the amount of protein
loaded in each lane.
Figure 6. Bid cleavage in Jurkat cells,
in response to granzyme B (GrB) and
anti-Fas (aFas) IgM. Western blot using
anti-Bid antiserum of Jurkat cells either
untreated (Cells), incubated with either
sublytic Perforin (Pfp) or PLO (P)
alone, Pfp/PLO in combination with
granzyme B (60 nM) for 2 h, or exposed
to anti-Fas IgM (250 ng/ml) for 4 h.
Tubulin (T) staining has been used to
ensure approximately equal protein
loading in the samples. 
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B (40). Cells exposed to anti-Fas IgM (250 ng/ml) for 4 h
showed somewhat reduced Bid processing, consistent with
slower death kinetics. We next compared the rate of Bid
processing in Jurkat cells expressing Bcl-2 or transfected
with empty vector alone (Fig. 7). In Jurkat.pgk cells treated
with granzyme B and porin, the signal due to intact Bid
was substantially reduced within just 2 min, and we ob-
served the coincident appearance of tBid molecules (
 
z
 
13
Figure 7. Bid is cleaved early
in Jurkat cells exposed to
granzyme B (GrB), irrespective
of Bcl-2 overexpression. Jurkat
cells overexpressing Bcl-2 or
transfected with vector backbone
DNA only (Jurkat-pgk) were ex-
posed for the times indicated to
granzyme B (60 nM) and sub-
lytic PLO. Control cells were
exposed to no stimulus (C) or
PLO alone (P). At each time
point, the cells were flooded
with ice-cold medium, pelleted
in a microfuge, washed twice in
ice-cold medium, then lysed for Western blot analysis with anti-Bid anti-
serum (see Materials and Methods). The migration of intact and tBid is
indicated by the arrowheads.
 
and 16 kD). Intact Bid was hardly visible by 80 min, and
absent by 120 min. Overexpression of Bcl-2 had only a mi-
nor effect on Bid processing. Cleavage of Bid was still seen
by 2 min; however, complete cleavage of intact Bid was
somewhat slowed in comparison with Bcl-2–nonexpressing
cells. It is likely that some of the later Bid cleavage seen in
the Jurkat-pgk cells was secondary to caspase activation, as
these cells underwent cell death whereas Jurkat-Bcl2 cells
remained viable and had little caspase activity (see below).
 
Kinetics of Bid and Caspase Cleavage in Response to
Granzyme B and Fas Ligation.
 
We next compared the
time course of Bid cleavage with cleavage of procaspase-3
and -9 in cells treated with granzyme B or Fas ligation (Fig.
8 A). Caspase-9 plays a pivotal role in activating down-
stream caspases after high order complex formation with
cytochrome c liberated from mitochondria and cytosolic
apoptotic protease-activating factor 1 (Apaf-1 [41]). Given
the apparent dependence of granzyme B–mediated killing
on the mitochondrial pathway, it was notable that pro-
caspase-9 was processed later than procaspase-3, with the
appearance of the signature 35-kD heavy chain only after
the cells had been exposed to granzyme B for 120 min (dis-
cussed further below). As observed previously, Bid cleavage
in response to granzyme B was rapid (complete by 20 min).
Figure 8. Time course of Bid and procaspase cleav-
age in response to granzyme B (GrB) or Fas ligation.
(A) Western blots of Jurkat cells incubated with anti-
Fas IgM Ab (250 ng/ml) or with sublytic PLO (P) with
or without granzyme B (60 nM) at 378C for the times
indicated. Cell lysates were fractionated on 15% SDS-
PAGE, transferred to nylon, and probed with the indi-
cated antisera (see Materials and Methods). (B) Western
blot using anti–caspase-3 antiserum of Jurkat cells overexpressing Bcl-2 or transfected with vector backbone (Jurkat.pgk). The cells were untreated (C) or
incubated with sublytic PLO (P) with or without granzyme B (60 nM) at 378C for the times indicated. To facilitate comparison, signals for 32-kD pro-
caspase-3 (Pro C3, top panels) are shown after a short exposure to x-ray film (15 s), and those for the cleavage products (bottom panels) are from longer
exposure (2 min). (C) Western blot using anti–caspase-8 antiserum of Jurkat cells overexpressing Bcl-2 or transfected with vector backbone (Jurkat.pgk).
The cells were untreated (C) or incubated with sublytic PLO (P) with or without granzyme B (60 nM) at 378C for the times indicated. To facilitate com-
parison, signals for 55-kD procaspase-8 (Pro C8, top panels) are shown after a short exposure to x-ray film (25 s), and those for the cleavage products
(bottom panels) are from longer exposure (3 min). 
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By comparison, treatment with anti-Fas IgM produced
only partial loss of the Bid signal by 120 min. Caspase-3 is
the earliest caspase activated during granzyme B–mediated
apoptosis of Jurkat cells (14). Partial activation of pro-
caspase-3 was seen within 10 min of exposure of cells to
granzyme B and either porin, with the appearance of a
 
z
 
20-kD form, a signature species that results from direct
cleavage of procaspase-3 by granzyme B at D175 (3, 10,
18). However, further processing to the mature and fully
active p19 and p17 forms (10) was seen only after 40 min.
Procaspase-3 cleavage to p19/17 in response to Fas ligation
was observed after 120 min without accumulation of the
20-kD species seen with granzyme B–mediated killing (Fig.
8 A). As partial processing of caspase-3 was an early event
compared with caspase-9 cleavage (see below), we wished
to determine its temporal relationship to Bid processing.
Using the same cell lysates as in Fig. 7, we found that the
initial processing of procaspase-3 was as rapid as Bid cleav-
age, and had commenced by the earliest time that could be
studied (2 min; Fig. 8 B). Interestingly, initial procaspase-3
cleavage was not delayed by Bcl-2 overexpression. How-
ever, further processing to p19 and p17 and loss of 32-kD
procaspase-3 seen with Jurkat.pgk cells was not seen over
the 2-h experiment. A similar pattern of procaspase-8 acti-
vation was also seen (Fig. 8 C). Partial processing to p43
was observed within 2 min irrespective of whether Bcl-2
was overexpressed; however, full processing to the mature
p18 chain was seen only in the absence of Bcl-2.
Previously, caspase-3 has been shown to cleave Bid only
at D59 (38). However, as both caspase-3 and Bid were
processed very rapidly in response to granzyme B, we
wished to exclude Bid processing by caspase-3 at the
granzyme B–preferred site (D75). Preincubation of Jurkat
cells with oligopeptide fmk derivatives that inhibit most
caspases had no effect on Bid processing (Fig. 9 A). Neither
z-VAD-fmk, a broad spectrum caspase inhibitor, nor
DEVD-fmk, which preferentially inhibits caspase-3 and re-
lated caspases, had any effect on Bid processing, despite
blocking caspase-dependent DNA fragmentation in re-
 
sponse to granzyme B (18; see also below; Fig. 9 A). In
contrast, Bid processing due to cross-linking of Fas was al-
most completely blocked by 20 
 
m
 
M z-VAD-fmk (Fig. 9
B). We again concluded that Bid is processed directly by
granzyme B at D75, and only secondarily by caspases.
 
Mitochondrial Perturbation in Response to Granzyme B Is In-
dependent of Caspases.
 
As Bid is processed directly by
granzyme B, we predicted that cleaved Bid should be capa-
ble of inducing mitochondrial perturbation without a re-
quirement for caspase activation. Therefore, we measured
changes in mitochondrial membrane potential under con-
ditions in which caspases were either active or inhibited by
fmk compounds (Fig. 10). Consistent with our previous re-
sults (18), preincubation of Jurkat cells in z-VAD-fmk or
DEVD-fmk reduced DNA fragmentation in response to
granzyme B and porin to background levels, confirming
that caspases had been blocked. However, neither z-VAD-
fmk nor DEVD-fmk had a significant influence on the loss
of mitochondrial membrane potential (measured as flux of
rhodamine 123 from the cells) in the same cell samples
compared with the control inhibitor z-FA-fmk, an inhibi-
tor of chymotrypsin-like proteases. Consistent with our
findings that Bcl-2 can abrogate apoptotic changes in re-
sponse to granzyme B and lead to long-term cell survival,
Bcl-2 overexpression in Jurkat cells also inhibited the loss
of mitochondrial membrane potential (24). Thus, prior
caspase activation is not necessary for mitochondrial pertur-
bation triggered by granzyme B, and this function can be
achieved by cleaved Bid, independently of caspases.
 
The Postmitochondrial Cell Death Signal: The Granzyme
B–induced Release of Cytochrome c from Mitochondria Is Largely
Dependent on Caspase Activation.
 
Having demonstrated
that mitochondrial perturbation is independent of caspase
activation, we wished to identify postmitochondrial effector
molecules responsible for the execution phase of cell death.
In some forms of apoptosis, mitochondrial disruption leads
to rapid caspase-9 activation through the liberation of mito-
chondrial cytochrome c from the intermembrane space into
the cytosol. Indeed, Bid cleaved in response to caspase-8
Figure 9. Cleavage of Bid in response to
granzyme B (GrB) is independent of caspases,
but is caspase dependent after Fas ligation. (A)
Western blot of Jurkat cells which were un-
treated (C) or incubated with sublytic PLO (P)
with or without granzyme B (60 nM) at 378C for the times indicated. Cell lysates were fractionated on 15%
SDS-PAGE, transferred to nylon, and probed with anti-Bid antiserum (see Materials and Methods). Before the
experiment, the cells were preincubated with the caspase inhibitors z-DEVD-fmk or z-VAD-fmk, or with the
control compound z-FA-fmk (20 mM) for 30 min at 378C. (B) Western blot of Jurkat cells which were un-
treated (C) or incubated with sublytic PLO (P) with or without granzyme B (60 nM) for 2 h or anti-Fas (aFas)
IgM (250 ng/ml) for 4 h at 378C. Cell lysates were probed with anti-Bid antiserum as in A. Before the experi-
ment, the cells were preincubated with z-VAD-fmk or z-FA-fmk (20 mM) for 30 min at 378C. 
1410
 
Granzyme B Initiates Apoptosis by Cleaving Bid
 
activation is thought to trigger cytochrome c release (36),
enabling formation of the apoptosome through recruitment
of the adaptor molecule Apaf-1. Given the very early ap-
pearance of tBid, we were surprised to find that procas-
pase-9 cleavage products were not detectable in cells treated
with granzyme B and porin until 2 h (Fig. 8 A). Cyto-
chrome c was released from mitochondria into the cytosol
in response to granzyme B and PLO; however, little or
no release was seen when caspases were inhibited with
z-VAD-fmk (Fig. 11). This result both indicated that cyto-
chrome c release is unlikely to contribute to early activation
of the caspase-9–dependent pathway in response to granzyme
B, and provided a rationale for the observed late cleavage of
procaspase-9.
 
Discussion
 
This study is the most comprehensive performed to date
dissecting the proximal events necessary for granzyme
B–mediated cell death. Our results strongly indicate that
rapid and direct cleavage of Bid at D75 is essential for trans-
mitting the granzyme B death signal to mitochondria, and
that mitochondrial disruption is both indispensable for
granzyme B–mediated death and necessary for efficient
caspase activation. Direct cleavage of caspases by granzyme
B does result in cell death unless caspase activation is also
augmented by mitochondrial perturbation. The findings
were consistent both in human Jurkat cells expressing en-
dogenous Bid and in mouse FDC-P1 cells in which over-
expressed Bid reversed Bcl-2’s block of apoptosis. Several
lines of evidence suggest that granzyme B cleaves Bid di-
rectly, rather than via the caspases. Bid was cleaved as early
as 2 min after exposure of cells to granzyme B, and this was
not delayed by fmk caspase inhibitors. More importantly,
overexpressed Bid lacking the granzyme B cleavage site
(D75E) was unable to overcome Bcl-2’s block of granzyme
B–mediated cell death, whereas Bid, which lacked the
caspase-8 cleavage site, still restored apoptosis. Finally, the
L90A Bid mutant, which is incapable of interacting with
mitochondrial Bcl-2, was cleaved by granzyme B, but
failed to restore cell death. This latter finding indicated that
wild-type Bid cleaved by granzyme B exerts its effects by
interacting with Bcl-2.
Mitochondrial perturbation resulting from direct cleav-
age of Bid accounts for caspase-dependent and -indepen-
dent cell death due to granzyme B. Our data allow us to
formulate a new model for granzyme B’s proapoptotic ac-
tivity (Fig. 12). Although granzyme B is a potent direct ac-
tivator of caspases in vitro, it acts predominantly through
the mitochondrial pathway in intact cells, and initiates the
process by directly cleaving Bid. Although at first perhaps
surprising, this mechanism can account for cell death oper-
ating either through caspases, or in their absence. In the ab-
sence of caspase inhibitors, the release of proapoptotic mi-
tochondrial constituents results in powerful augmentation
Figure 10. Loss of mitochondrial
membrane depolarization in re-
sponse to granzyme B is indepen-
dent of caspases. Loss of rhodamine
123 (Rh123) accumulation in Jurkat
cells after exposure to granzyme B
(GrB, 60 nM) and sublytic PLO (P)
for 2 h. The same cell samples were
also analyzed for DNA fragmenta-
tion by TUNEL and for changes in
forward and side scatter characteris-
tics by flow cytometry at 2 h. Before
commencement of the experiment,
the cells were preincubated with the
caspase inhibitors z-DEVD-fmk or
z-VAD-fmk, or with the control
compound z-FA-fmk (each 100
mM) for 30 min at 378C. The nu-
merals indicate the percentage of
rhodamine-positive or -negative
cells, or TUNEL-positive cells, to
the nearest integer.
Figure 11. Release of cytochrome c from mitochondria in response to
granzyme B is dependent on caspase activation. Jurkat cells were preincu-
bated with 20 mM z-VAD-fmk or without inhibitor for 30 min at 378C,
then exposed to sublytic PLO (P) with or without granzyme B (GrB) for
2 h at 378C. The cells were then washed, lysed, and cytosolic extracts de-
void of mitochondria prepared by ultracentrifugation. The extracts were
analyzed in Western blots using antisera for cytochrome c (cyt. c) or tu-
bulin (T) (see Materials and Methods). 
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of caspases (the caspase-dependent pathway, discussed fur-
ther below). Inhibition of caspase activity, for instance by
p35, results in loss of DNA fragmentation (17, 18) and
poly(ADP-ribose) polymerase cleavage in response to
granzyme B (3); however, cell growth and clonogenic as-
says clearly indicate that caspase-independent death path-
ways remain intact and cell death still occurs (18, 24). Our
model predicts that tBid-induced mitochondrial disruption
by itself is sufficient to kill a cell when caspases are not ac-
tive, as supported by our finding that loss of mitochondrial
membrane depolarization occurs despite caspase inactiva-
tion with z-VAD-fmk.
The fact that Bcl-2 overexpression fully restores clono-
genic capacity to granzyme B–treated cells (24) shows that
Bcl-2 governs an essential proximal step that regulates both
the caspase-dependent and -independent pathways. We also
showed that missorting of Bcl-2 to the inner leaflet of the
plasma membrane abolished its ability to block granzyme B
(24). In light of this study, it is evident that missorting of
Bcl-2 would prevent it from negating the mitochondrial
disruption induced after Bid cleavage. Our observation that
Bid is the proximal mediator of mitochondrial disruption
due to granzyme B is thus consistent both with the central-
ity of the mitochondrial pathway and the existence of death
pathways that operate independently of caspases.
 
How does granzyme B bring about full caspase activation
in intact cells? We observed that although partial processing
of caspase-3 and -8 is an early event after exposure to
granzyme B, further processing is lost when Bcl-2 is over-
expressed. A major question that remains is why caspase ac-
tivation stalls in Bcl-2–overexpressing cells. It has been
proposed that initial cleavage of procaspase-3 by granzyme
B is sufficient for further autocatalysis to fully activate
caspase-3 (14, 18). Our data suggest that initial granzyme B
cleavage of procaspase-3 does not predispose the caspase-3
precursor to full processing, unless mitochondrial perturba-
tion also occurs through tBid (Fig. 12). Mitochondrial dis-
ruption classically results in caspase recruitment through
cytochrome c–dependent complex formation with Apaf-1
and procaspase-9. However, we found that caspase-9 is ac-
tivated well after caspase-3, and that cytochrome c is not
liberated from mitochondria without prior caspase activa-
tion. Therefore, we argue that cytochrome c does not play
a primary role in granzyme B–mediated caspase activation.
Rather, it is likely that the late release of cytochrome c fur-
ther amplifies the already activated caspase cascade. This
view is supported by the recent finding that overexpression
of 27-kD heat shock protein blocked caspase-9–dependent
apoptosis by sequestering cytochrome c, but did not influ-
ence granzyme B–induced caspase activation (42).
As a mitochondrial cofactor contributing to caspase acti-
vation is strongly suggested by our data, we believe a factor
other than cytochrome c (factor “X”; Fig. 12) may be re-
sponsible for efficient processing of caspase-3. This hy-
pothesis is consistent with the finding that adding mito-
chondria to granzyme B–activated cytosolic lysate greatly
amplified caspase-3 activity (28). In light of this, it was
interesting that in non–Bcl-2–expressing Jurkat cells,
caspase-3 processing seemed to take place in two stages.
After rapid processing to the p20 form (
 
,
 
2 min), further
maturation was delayed until 
 
z
 
40 min (Fig. 8 A). Soon
thereafter, the p19 and p17 forms were clearly present,
with depletion of the 32-kD form. A candidate for this fa-
cilitatory role is the recently described protein direct inhib-
itor of apoptosis proteins (IAP) binding protein (DI-
ABLO)/second mitochondria-derived activator of caspase
(Smac) which, when released from mitochondria, facili-
tates further processing of caspases by antagonizing the ac-
tivity of the inhibitory factor mammalian IAP homolog A
(MIHA)/X chromosome–linked inhibitor of apoptosis
(XIAP) (43, 44). In Bcl-2–overexpressing cells, the first
stage of procaspase processing (inefficient, and due to di-
rect procaspase cleavage by granzyme B) can take place,
but not the second, which relies on mitochondrial disrup-
tion. Thus, caspase-3 activity never reaches a threshold
level that can kill the cell. As the form of tBid produced by
granzyme B cleavage at D75 did not induce cytochrome c
release, we also speculate that this product may preferen-
tially release an alternative cofactor. In this context, it may
be relevant that the release of DIABLO/Smac and cyto-
chrome c have been shown to be separately regulated (45).
In conclusion, this study reinforces our proposition
(23, 24) that the mitochondrial pathway is essential for
Figure 12. A unifying model of granzyme B–mediated cell death. Im-
mediately upon accessing the cytosol, granzyme B principally cleaves Bid
(thick arrow) and partially activates procaspase-3 (dotted arrows). How-
ever, caspase-3 is not fully processed unless tBid primarily disrupts the mi-
tochondrion, a step that is regulated by Bcl-2 overexpression. Activation
of other caspases is downstream of caspase-3 or related DEVD-fmk–inhib-
itable caspases. Mitochondrial perturbation by Bid results in cell death that
is independent of caspases, and therefore is not blocked by p35. The mito-
chondrial factor responsible for full caspase activation is unknown (factor
X), but is not cytochrome c, the release of which also requires further
(secondary) mitochondrial damage resulting from full caspase activation
(see text). We speculate, without any evidence, that this factor may be
similar to DIABLO/Smac, a protein that, when released from mitochon-
dria, displaces IAP inhibitors from some caspases to allow full activation. 
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granzyme B–mediated cell death, and strongly implicates
Bid as the molecule that rapidly transmits a death signal to
mitochondria. Although direct processing of pro-caspases
by granzyme B can occur, this process does not achieve a
lethal threshold of caspase activity unless mitochondrial
perturbation is also induced by granzyme B–cleaved tBid.
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